Citation Impact
Citing Papers
Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders
2009
Tumor Vaccines Expressing Flt3 Ligand Synergize with CTLA-4 Blockade to Reject Preimplanted Tumors
2009 StandoutNobel
RNA-Guided Human Genome Engineering via Cas9
2013 StandoutScience
In Vivo Profiling of Hypoxic Gene Expression in Gliomas Using the Hypoxia Marker EF5 and Laser-capture Microdissection
2011
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures
2011
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Improved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickase
2016 StandoutNobel
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Cancer statistics, 2024
2024 Standout
Priming of naive T cells inside tumors leads to eradication of established tumors
2004
Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small Cell Lung Cancer
2010
Targeting hypoxia in cancer therapy
2011 Standout
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations
2017
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
The emerging role of p53 in stem cells
2011
Cancer Metastasis: Building a Framework
2006 Standout
Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion
2006
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
2005 Standout
Coordinated regulation of myeloid cells by tumours
2012 Standout
Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors
2006
Generation of mouse-induced pluripotent stem cells with plasmid vectors
2010 StandoutNobel
Reprogramming Cellular Identity for Regenerative Medicine
2012
Induced pluripotency: history, mechanisms, and applications
2010
Mechanisms of nuclear reprogramming by eggs and oocytes: a deterministic process?
2011 StandoutNobel
Generation of Induced Pluripotent Stem Cell Lines from Tibetan Miniature Pig
2009
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
The CXCR3 Targeting Chemokine CXCL11 Has Potent Antitumor Activity In Vivo Involving Attraction of CD8+ T Lymphocytes But Not Inhibition of Angiogenesis
2005
Immunogenicity of induced pluripotent stem cells
2011 StandoutNature
Super-Enhancers in the Control of Cell Identity and Disease
2013 Standout
Gene Targeting of a Disease-Related Gene in Human Induced Pluripotent Stem and Embryonic Stem Cells
2009
Dual biological effects of the cytokines interleukin-10 and interferon-γ
2011
Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function
2010
Inflammatory cell infiltration of tumors: Jekyll or Hyde
2007
The essence of senescence: Figure 1.
2010 Standout
The Role of Prostaglandins and Other Eicosanoids in the Gastrointestinal Tract
2005
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Intratumoral forkhead box P3‐positive regulatory T cells predict poor survival in cyclooxygenase‐2–positive uveal melanoma
2010
Induced pluripotent stem cells and reprogramming: seeing the science through the hype
2009 StandoutNobel
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
2010 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Immortalization eliminates a roadblock during cellular reprogramming into iPS cells
2009 Nature
Microenvironmental regulation of metastasis
2008 Standout
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
Efficient Feeder-Free Episomal Reprogramming with Small Molecules
2011
Immunotherapy for pancreatic cancer — science driving clinical progress
2005
Cancer-related inflammation
2008 StandoutNature
Induced Neuronal Cells: How to Make and Define a Neuron
2011 StandoutNobel
Cervical cancer
2019 Standout
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Immune surveillance: a balance between protumor and antitumor immunity
2008
Integration-Free iPS Cells Engineered Using Human Artificial Chromosome Vectors
2011 StandoutNobel
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Targeting cyclooxygenase-2 in human neoplasia
2003
Organoid single-cell genomic atlas uncovers human-specific features of brain development
2019 StandoutNatureNobel
Modeling Development and Disease with Organoids
2016 Standout
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Nuclear reprogramming to a pluripotent state by three approaches
2010 StandoutNatureNobel
High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity
2013 StandoutNobel
Interleukin-10 and the immune response against cancer: a counterpoint
2005
An Efficient Nonviral Method to Generate Integration-Free Human-Induced Pluripotent Stem Cells from Cord Blood and Peripheral Blood Cells
2012 StandoutNobel
Dendritic cell dysfunction in cancer: A mechanism for immunosuppression
2005
Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
2013
Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE2 catabolism in myeloid cells
2010
The discovery and development of cyclooxygenase-2 inhibitors as potential anticancer therapies
2014
Recent Stem Cell Advances: Induced Pluripotent Stem Cells for Disease Modeling and Stem Cell–Based Regeneration
2010 StandoutNobel
Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells
2012 StandoutNobel
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Cyclooxygenase-2–Dependent Regulation of E-Cadherin: Prostaglandin E2 Induces Transcriptional Repressors ZEB1 and Snail in Non–Small Cell Lung Cancer
2006
Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease
2011
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Image-guided adaptive brachytherapy in locally advanced cervical cancer: recent advances and perspectives
2016
Stoichiometric and temporal requirements of Oct4, Sox2, Klf4, and c-Myc expression for efficient human iPSC induction and differentiation
2009
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
Cervical cancer: A global health crisis
2017
Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery
2017 StandoutNobel
Prostaglandin E2 Promotes Tumor Progression by Inducing Myeloid-Derived Suppressor Cells
2007
Human Dendritic Cells Produce TGF-β1 under the Influence of Lung Carcinoma Cells and Prime the Differentiation of CD4+CD25+Foxp3+ Regulatory T Cells
2009
Induced pluripotent stem cells: opportunities and challenges
2011 StandoutNobel
Tumor Cyclooxygenase-2/Prostaglandin E2–Dependent Promotion of FOXP3 Expression and CD4+CD25+ T Regulatory Cell Activities in Lung Cancer
2005
Works of Jeff Lin being referenced
SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10.
2003
The Role of High-Risk Human Papilloma Virus Testing in the Surveillance of Cervical Cancer After Treatment
2015
National Cancer Data Base Analysis of Radiation Therapy Consolidation Modality for Cervical Cancer: The Impact of New Technological Advancements
2014
Disparities in treatment and survival for women with endometrial cancer: A contemporary national cancer database registry analysis
2016
Improved Efficiency and Pace of Generating Induced Pluripotent Stem Cells from Human Adult and Fetal Fibroblasts
2008
Cyclooxygenase 2 Inhibition Promotes IFN-γ-Dependent Enhancement of Antitumor Responses
2005
Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.
2003